Early Use of Sotrovimab in Children: A Case Report of an 11-Year-Old Kidney Transplant Recipient Infected with SARS-CoV-2

• Váldodahkkit: Costanza Di Chiara (Dahkki), Daniele Mengato (Dahkki), Marica De Pieri (Dahkki), Germana Longo (Dahkki), Elisa Benetti (Dahkki), Francesca Venturini (Dahkki), Carlo Giaquinto (Dahkki), Daniele Donà (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2022-03-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: The use of virus-neutralizing monoclonal antibodies has been approved in fragile populations, including kidney transplant recipients, who are at risk of developing severe COVID-19. Sotrovimab is the only currently available anti-SARS-CoV-2 neutralizing monoclonal antibody with activity a...